SCHEMBL23853424

SCHEMBL23853424

CCCCCCC(OCCC)=C(OCCC)OCOC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.39
DNM1 Q05193 1/20 0.33
PAM P19021 2/20 0.33
CES2 O00748 3/20 0.32
CES1 P23141 3/20 0.32
NAAA Q02083 1/20 0.32
GPR84 Q9NQS5 6/20 0.31
PPARG P37231 6/20 0.31
PPARD Q03181 6/20 0.31
PPARA Q07869 6/20 0.31
HDAC11 Q96DB2 5/20 0.31
TSHR P16473 4/20 0.31
ALDH1A1 P00352 2/20 0.31
TLR2 O60603 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
FABP4 P15090 2/20 0.31
PTPN1 P18031 2/20 0.31
SLC22A6 Q4U2R8 1/20 0.31
SLC22A8 Q8TCC7 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23853421 1.00 DGKA (0.39) DGKADNM1PAMCES2CES1
SCHEMBL23853305 1.00 DGKA (0.39) DGKADNM1PAMCES2CES1
SCHEMBL23852980 1.00 DGKA (0.39) DGKADNM1PAMCES2CES1
SCHEMBL23853307 1.00 DGKA (0.39) DGKADNM1PAMCES2CES1
SCHEMBL23852461 1.00 DGKA (0.39) DGKADNM1PAMCES2CES1
SCHEMBL23852276 1.00 DGKA (0.39) DGKADNM1PAMCES2CES1
SCHEMBL23853246 1.00 DGKA (0.39) DGKADNM1PAMCES2CES1
SCHEMBL23852273 1.00 DGKA (0.39) DGKADNM1PAMCES2CES1
SCHEMBL23852979 1.00 DGKA (0.39) DGKADNM1PAMCES2CES1
SCHEMBL23852460 1.00 DGKA (0.39) DGKADNM1PAMCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114380673-B Dialkoxy alkenyl alkoxy methyl ether compound and method for preparing terminal conjugated alkadiene aldehyde compound from same 信越化学工业株式会社 2024-09-13 CN disclosed
EP-3978466-B1 DIALKOXYALKENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A TERMINAL CONJUGATED ALKADIENAL COMPOUND FROM THE SAME SHINETSU CHEMICAL CO (JP) 2023-07-12 EP disclosed
EP-3885334-B1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME SHINETSU CHEMICAL CO (JP) 2023-01-11 EP disclosed
US-11420919-B2 Process for preparing a formylalkenyl alkoxymethyl ether compound and processes for preparing conjugated diene compounds from the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-08-23 US disclosed
US-11414368-B2 Dialkoxyalkenyl alkoxymethyl ether compound and a process for preparing a terminal conjugated alkadienal compound from the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-08-16 US disclosed
US-20220106247-A1 DIALKOXYALKENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A TERMINAL CONJUGATED ALKADIENAL COMPOUND FROM THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-04-07 US disclosed
EP-3978466-A1 DIALKOXYALKENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A TERMINAL CONJUGATED ALKADIENAL COMPOUND FROM THE SAME Shin-Etsu Chemical Co., Ltd. (JP) 2022-04-06 EP disclosed
US-20210300854-A1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-09-30 US disclosed
EP-3885334-A1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME Shin-Etsu Chemical Co., Ltd. (JP) 2021-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300854-A1 PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME ADH1C, ORC3, ADH1A DGKA 1667/4885DNM1 1759/4885PAM 336/4885
US-11420919-B2 Process for preparing a formylalkenyl alkoxymethyl ether compound and processes for preparing conjugated diene compounds from the same ADH1C, ORC3, ADH1A DGKA 1667/4885DNM1 1759/4885PAM 336/4885
US-11414368-B2 Dialkoxyalkenyl alkoxymethyl ether compound and a process for preparing a terminal conjugated alkadienal compound from the same OR10J3, AKR1C3, ORC3 DGKA 1842/4885DNM1 4470/4885PAM 272/4885
US-20220106247-A1 DIALKOXYALKENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A TERMINAL CONJUGATED ALKADIENAL COMPOUND FROM THE SAME OR10J3, AKR1C3, ORC3 DGKA 1842/4885DNM1 4470/4885PAM 272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.